To our knowledge, only two recently published papers reported preventive effects of two compounds (glycyrrhizin and YC-1) against tPA-induced HT via the suppression of HMGB1/TLR2 or HMGB1/TLR4 signaling in ischemic stroke rats [21, 22]. This evidence concerns the gene TLR4 and hematocrit.